Extended Data Fig. 5: Responders to Matched Targeted Therapy.
From: Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer
Details of 5 responders to matched targeted therapy. GAIN patient 317 with an ALK fusion in a medullary thyroid carcinoma also responded, with images available in the primary report (Hillier et al., 2019).
